MarketBeat
Sat, May 2, 2026 astatine 2:07 PM CDT 6 min read
Key Points
-
FMC reported full-year 2025 gross of $3.47 cardinal (down 18% vs. 2024), adjusted EBITDA of $843 cardinal and adjusted EPS of $2.96, and launched Project Foundation to trim structural costs — including shifting immoderate accumulation to lower‑cost sites and moving to merchantability its India commercialized business, a transaction expected to adjacent successful 2026.
-
In February the committee authorized a process to research strategic alternatives, including a imaginable merchantability of the company, portion absorption says it volition proceed executing the 2026 operational program to maximize shareholder value.
-
FMC’s innovation pipeline showed momentum: income of its 3 newest progressive ingredients reached astir $200 cardinal successful 2025 (up 54% year‑over‑year), and the combined long‑term income imaginable of 4 caller molecules is expected to transcend $2 billion.
-
Interested successful FMC Corporation? Here are 5 stocks we similar better.
-
Small-Cap Surge: 3 Stocks Ready to Ride the Market Rotation
FMC (NYSE:FMC) shareholders heard an overview of the company’s 2025 show and strategical priorities for 2026 during the company’s 97th yearly meeting, led by Chairman, CEO and President Pierre Brondeau. The virtual gathering besides included voting connected manager elections and a bid of governance and compensation-related proposals.
Leadership remarks and committee updates
Brondeau opened the gathering by noting that shareholders could taxable questions done the virtual gathering website, with pertinent questions addressed astatine the extremity of the gathering and posted aboriginal to the company’s capitalist relations site.
→ Meta Posted Its Best Sales Growth Since 2021—So Why Did Shares Fall?
-
How Trump’s AI Push Could Boost These 3 Agriculture Stocks
He introduced the committee members successful attendance and paused to retrieve Dirk A. Kempthorne, a manager since 2009, who precocious died. Brondeau besides recognized 3 retiring directors: C. Scott Greer, Margareth Øvrum, and Robert C. Pallash.
Brondeau introduced representatives from KPMG LLP, including Audit Partner John Walker and Managing Director Steven Venn, who joined the meeting.
2025 fiscal results and actions taken
→ Verizon’s Signal Strength: The Turnaround Call Is Loud and Clear
-
How a New Agriculture Boom Could Propel FMC Stock Higher
Brondeau characterized 2025 arsenic “a pivotal year” successful which FMC faced continued marketplace challenges portion taking steps to reposition the institution and beforehand its innovation pipeline. He noted his remarks referenced non-GAAP measures, with reconciliations disposable connected FMC’s website.
For full-year 2025, Brondeau reported:
-
Revenue of $3.47 billion, down 18% versus 2024 and down 8% excluding Civil Health USL
-
Adjusted EBITDA of $843 million, down 7%
-
Adjusted net per share of $2.96, down 15%
-
Adjusted EBITDA margin of 22%

1 hour ago
1




English (CA) ·
English (US) ·
Spanish (MX) ·